Our research provides novel insights into the tumor metabolism and growth mechanisms of nasopharyngeal carcinoma, and identifies ELAVL1 as a promising potential therapeutic target for this disease. The gene discussed is ELAVL1; the disease is nasopharyngeal carcinoma.